Search results
Bristol Myers signs $380 million CAR-T therapies supply deal with Cellares
Reuters via Yahoo Singapore Finance· 2 months ago(Reuters) -Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract...
Bristol Myers Squibb and Cellares reach $380 mln supply deal for CAR-T therapies
Reuters via Yahoo Singapore Finance· 2 months agoApril 22 (Reuters) - Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell therapies to more patients. (Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
US FDA mandates label updates on CAR-T cancer therapies
Reuters via Yahoo Singapore Finance· 3 months agoThe U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called "boxed warning" to highlight the serious risk of T-cell ...
UPDATE 3-US FDA investigating safety risk of CAR-T cancer therapies
Reuters via Yahoo Singapore Finance· 7 months agoThe U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by companies such as Gilead Sciences, Johnson & Johnson and Novartis over the risk of hospitalizations ...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News Singapore· 1 month ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery
Reuters via Yahoo Singapore Finance· 6 months agoThe U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022,...
Moderna shares fall after judge sides with Arbutus in patent fight
Reuters via Yahoo Singapore Finance· 3 months agoRoivant's shares gained 4% in afternoon trading, while its subsidiary Arbutus rose more than 17%. In...
AstraZeneca to buy China's Gracell Biotechnologies in $1.2 billion deal
Reuters via Yahoo Singapore Finance· 6 months ago(Reuters) -AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as...
UPDATE 4-Masimo prepared to provide one board seat if activist Politan drops proxy contest
Reuters via Yahoo Singapore Finance· 2 months agoMasimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee ...
Surging bills, fewer showers: India's Bengaluru reels under water shortage
Reuters via Yahoo News Singapore· 4 months agoBengaluru is facing an acute water shortage this year, months before peak summer, forcing many residents in "India's Silicon Valley" to ration their water use and pay almost double the usual ...
